The Importance of Spatial Distribution of Stemness and Proliferation State in Determining Tumor Radioresponse

被引:52
作者
Enderling, H. [1 ]
Park, D. [1 ]
Hlatky, L. [1 ]
Hahnfeldt, P. [1 ]
机构
[1] Tufts Univ, Sch Med, Caritas St Elizabeths Med Ctr, Ctr Canc Syst Biol, Boston, MA 02135 USA
基金
美国国家航空航天局;
关键词
cancer; stem cell; radiotherapy; quiescence; proliferation; repopulation; ACUTE MYELOID-LEUKEMIA; EARLY BREAST-CANCER; SOLID TUMORS; MATHEMATICAL-MODEL; CELL-DEATH; RADIOTHERAPY; GROWTH; IDENTIFICATION; TISSUE; CHEMOTHERAPY;
D O I
10.1051/mmnp/20094305
中图分类号
Q [生物科学];
学科分类号
090105 [作物生产系统与生态工程];
摘要
Tumor growth and progression is a complex phenomenon dependent on the interaction of multiple intrinsic and extrinsic factors. Necessary for tumor development is a small subpopulation of potent cells, so-called cancer stem cells, that can undergo an unlimited number of cell divisions and which are proposed to divide symmetrically with a small probability to produce more cancer stem cells. We show that the majority of cells in a tumor must indeed be non-stem cancer cells with limited life span and limited replicative potential. Tumor development is dependent as well on the proliferative potential and death of these cells, and on the migratory ability of all cancer cells. With increasing number of cells in the tumor, competition for space limits tumor progression, and in agreement with in vitro observation, the majority of cancer cells become quiescent, with proliferation primarily occurring on the outer rim where space is available. We present an agent-based model of early tumor development that captures the spatial heterogeneity of stemness and proliferation status. We apply the model to simulations of radiotherapy to predict treatment outcomes for tumors with different stem cell pool sizes and different quiescence radiosensitivities. We show by first presuming homogeneous radiosensitivity throughout the tumor, and then considering the greater resistance of quiescent cells, that stem cell pool size and stem cell repopulation during treatment determine treatment success. The results for tumor cure probabilities comprise upper bounds, as there is evidence that cancer stem cells are also more radioresistant than other tumor cells. Beyond just demonstrating the influence of mass effects of stem to non-stem cell ratios and proliferating to quiescent cell ratios, we show that the spatiotemporal evolution of the developing heterogeneous population plays a pivotal role in determining radioresponse and treatment optimization.
引用
收藏
页码:117 / 133
页数:17
相关论文
共 55 条
[1]
Prospective identification of tumorigenic breast cancer cells [J].
Al-Hajj, M ;
Wicha, MS ;
Benito-Hernandez, A ;
Morrison, SJ ;
Clarke, MF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (07) :3983-3988
[2]
Alarcon T, 2006, COMPUT MATH METHOD M, V7, P85, DOI [DOI 10.1080/10273660600968994, 10.1080/10273660600968994]
[3]
Anderson ARA, 2007, SINGLE CELL BASED MO
[4]
THE AGE DISTRIBUTION OF CANCER AND A MULTI-STAGE THEORY OF CARCINOGENESIS [J].
ARMITAGE, P ;
DOLL, R .
BRITISH JOURNAL OF CANCER, 1954, 8 (01) :1-12
[5]
It takes a tissue to make a tumor: Epigenetics, cancer and the microenvironment [J].
Barcellos-Hoff, MH .
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2001, 6 (02) :213-221
[6]
Barendsen GW, 2001, INT J ONCOL, V19, P247
[7]
Targeted Intra-operative Radiotherapy-TARGIT for Early Breast Cancer Can We Spare the Patient Daily Journeys to the Radiotherapist? [J].
Baum, Michael ;
Vaidya, Jayant S. .
RECENT ADVANCES IN CLINICAL ONCOLOGY, 2008, 1138 :132-135
[8]
Exploring the role of cancer stem cells in radioresistance [J].
Baumann, Michael ;
Krause, Mechthild ;
Hill, Richard .
NATURE REVIEWS CANCER, 2008, 8 (07) :545-554
[9]
Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)60348-7, 10.1016/S1470-2045(08)70077-9]
[10]
ADVANCES IN DIAGNOSTIC-IMAGING AND OVERESTIMATIONS OF DISEASE PREVALENCE AND THE BENEFITS OF THERAPY [J].
BLACK, WC ;
WELCH, HG .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (17) :1237-1243